Disease Activity and Therapeutic Response to Pegcetacoplan for Geographic Atrophy Identified by Deep Learning-Based Analysis of OCT
Top Cited Papers
Open Access
- 14 August 2024
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 132 (2) , 181-193
Abstract
No abstract availableKeywords
Funding Information
- Apellis Pharmaceuticals
This publication has 40 references indexed in Scilit:
- Systems genomics in age-related macular degenerationExperimental Eye Research, 2022
- Inhibition of Complement Factor 3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study ResultsAmerican Journal of Ophthalmology, 2022
- Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic AtrophyOphthalmology, 2021
- Imaging Features Associated with Progression to Geographic Atrophy in Age-Related Macular DegenerationOphthalmology Retina, 2021
- Progression of Photoreceptor Degeneration in Geographic Atrophy Secondary to Age-related Macular DegenerationJAMA Ophthalmology, 2020
- Role of Deep Learning–Quantified Hyperreflective Foci for the Prediction of Geographic Atrophy ProgressionAmerican Journal of Ophthalmology, 2020
- Cellular Characterization of OCT and Outer Retinal Bands Using Specific Immunohistochemistry Markers and Clinical ImplicationsOphthalmology, 2018
- Photoreceptor Damage and Reduction of Retinal Sensitivity Surrounding Geographic Atrophy in Age-Related Macular DegenerationAmerican Journal of Ophthalmology, 2016
- Microperimetry Features of Geographic Atrophy Identified With En Face Optical Coherence TomographyJAMA Ophthalmology, 2016
- Square Root Transformation of Geographic Atrophy Area Measurements to Eliminate Dependence of Growth Rates on Baseline Lesion Measurements: A Reanalysis of Age-Related Eye Disease Study Report No. 26JAMA Ophthalmology, 2013